Metabolic Imaging Biomarkers of Response to Signaling Inhibition Therapy in Melanoma is a research paper published in Cancers (2024). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institues of Health
Grant: R01CA250102
National Institues of Health
Grant: R01CA228457
National Institues of Health
Grant: R01CA268601
National Institutes of Health
Grant: 5R01CA228457-03
Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition
National Institutes of Health
Grant: 5R01CA268601-03
Metabolic Imaging of Targeted Therapies in Cancer
National Institutes of Health
Grant: 5R01CA250102-05
Melanoma: Metabolic Biomarkers of Response to Targeted Therapy
FWCI
1.09
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals